Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126139921 | 12613992 | 1 | I | 20160718 | 0 | 20160801 | 20160801 | DIR | 34.63 | YR | F | N | 49.70000 | KG | 20160719 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126139921 | 12613992 | 1 | PS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 4J006 | 201710 | 0 | 912 | MG | ||||||||
| 126139921 | 12613992 | 2 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | M27179,M93558 | 201704,2 | 0 | 91 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126139921 | 12613992 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126139921 | 12613992 | Dehydration | |
| 126139921 | 12613992 | Dyspnoea | |
| 126139921 | 12613992 | Hypocalcaemia | |
| 126139921 | 12613992 | Hypomagnesaemia | |
| 126139921 | 12613992 | Hyponatraemia | |
| 126139921 | 12613992 | Nausea | |
| 126139921 | 12613992 | Paraesthesia | |
| 126139921 | 12613992 | Peripheral swelling | |
| 126139921 | 12613992 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126139921 | 12613992 | 1 | 20160718 | 0 | ||
| 126139921 | 12613992 | 2 | 20160718 | 0 |